TargetAmp Selection Guide TargetAmp Process TargetAmp Performance TargetAmp FAQs TargetAmp Poster TargetAmp Citations
aRNA, Aminoallyl-aRNA, or Biotin-aRNA Yield and Fold-Amplification The TargetAmp RNA Amplification Kits are optimized for use with SuperScript II and SuperScript III Reverse Transcriptase enzymes and incorporate EPICENTRE Biotechnologies' AmpliScribe™ T7 High Yield in vitro transcription technology. In addition, the kits utilize a proprietary chemistry that virtually eliminates non-specific amplification products. The result is a TargetAmp RNA amplification reaction that produces extremely high yields of aRNA (or aminoallyl-aRNA or biotin-aRNA) with virtually no non-specific amplification product. Table 1. Yields of aRNA obtained using the TargetAmp™ 1-Round aRNA Amplification Kit 103. Results are the average of multiple experiments using the HeLa Total RNA. Yields of aminoallyl-aRNA using the TargetAmp™ 1-Round aRNA Amplification Kit 101 and biotin-aRNA using the TargetAmp™ 1-Round Biotin-aRNA Amplification Kit 105 are essentially the same.
Table 2. Yields of aRNA obtained using the TargetAmp™ 2-Round
aRNA Amplification Kit 2.0.
Size of the aRNA Produced The size of the aminoallyl-aRNA produced by the TargetAmp 2-Round Aminoallyl-aRNA Kit 1.0 was investigated using two different amounts of input total RNA. Total RNA from a single laser captured rat dorsal root ganglion cell (about 10 pg) and 200 pg of total RNA from rat brain were independently amplified using the TargetAmp 2-Round Aminoallyl-aRNA Amplification Kit 1.0. The size distribution of the resulting aminoallyl-aRNA produced from the rat dorsal root ganglion cell was analyzed by denaturing agarose gel electrophoresis (Figure 1a) and the aminoallyl-aRNA generated from the rat brain cells was analyzed using an Agilent 2100 Bioanalyzer (Figure 1b). In both examples, the aminoallyl-aRNA produced had an average size of greater than 600 bases.
Reproducibility of the TargetAmp
RNA Amplification Reaction
Preservation of Gene Expression Levels (Preservation of Relative Abundance of Transcripts) The relative expression level of a panel of genes in Universal Human Reference RNA (Stratagene) and adult skeletal muscle total RNA was assessed before and after TargetAmp 1-Round and TargetAmp 2-Round amplification reactions. Unamplified RNA and aRNA produced by a TargetAmp 1-Round and a TargetAmp 2-Round amplification reaction was reverse transcribed using random primers and Superscript III Reverse Transcriptase. Quantitative PCR (SYBRŪ Green detection) was performed using EPICENTRE Biotechnologies' TAQurate GREEN Real-Time PCR MasterMix. Beta-2 microglobulin was used for expression level normalization. The differences in expression levels between the RNA samples are represented as the normalized ΔCT in qPCR cycles (ΔΔCT). The results presented in the chart below demonstrate that both the TargetAmp 1-Round and 2-Round amplification reactions preserve the relative expression levels of genes.
Correlation of Differential
Gene Expression (Fidelity of Amplification) The resulting biotin-aRNA samples were fragmented and hybridized to Affymetrix GeneChip Mouse Genome 430 2.0 Arrays, in triplicate. Differentially expressed genes were identified using the GeneSpring software package (Silicon Genetics). The expression ratios obtained with the Affymetrix protocol and with the TargetAmp 1-Round Aminoallyl-aRNA Amplification Kit 101 protocol are plotted in Figure 3A below. The correlation coefficient of 0.90 demonstrates good agreement between differentially expressed genes identified by the TargetAmp Kit 101 protocol and by the standard Affymetrix labeling method. The expression ratios obtained with the TargetAmp 2-Round Aminoallyl-aRNA Kit 1.0 protocol and with the Affymetrix protocol are plotted in Figure 3B. A correlation coefficient of 0.89 demonstrates good agreement between differentially expressed genes identified using biotin-aRNA target produced by the TargetAmp Kit 1.0 and conjugated to Biotin-X-X-NHS and by the standard Affymetrix labeling method.
Quality Assessment on GeneChip® Arrays (3'
to 5' Ratios and % Present Calls) Table 3. AA-aRNA produced using the TargetAmp™ 1-Round Aminoallyl-aRNA Amplification Kit 101, and subsequently biotinylated, produced high quality GeneChip Arrays as determined by Affymetrix quality assessment guidelines.
Performance of biotin-aRNA prepared using the TargetAmp 2-Round Aminoallyl-aRNA Amplification 1.0 protocol was also evaluated on the Affymetrix GeneChip platform. Four hundred picograms (400 pg) of total RNA from 6-day and 12-day cultured mouse neural cells was independently amplified using the TargetAmp 2-Round Aminoallyl-aRNA Amplification Kit 1.0. The resulting aminoallyl-aRNA was labeled by conjugation to EPICENTRE's Biotin-X-X-NHS using a standard conjugation procedure. The resulting biotin-aRNA was fragmented and hybridized to GeneChip Mouse Genome 430 2.0 Arrays, in triplicate, by the Gene Expression Center of the University of Wisconsin Biotechnology Center. The averages of the 3’-to-5’ ratios and Present Calls were determined with the MAS 5 software (Affymetrix) and are shown in Table 4. The data demonstrates the high quality arrays that are obtained with biotin-aRNA target prepared using the TargetAmp 2-Round Aminoallyl-aRNA Amplification Kit 1.0 and Biotin-X-X-NHS. Table 4. AA-aRNA produced using the TargetAmp™ 2-Round Aminoallyl-aRNA Amplification Kit 1.0, and subsequently biotinylated, generated high quality GeneChip Arrays.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
HOME | PRODUCTS | WHAT'S NEW | ORDERING | TECHNICAL RESOURCES | CONTACT US | ABOUT US EPICENTRE® Biotechnologies - Understanding the Genome
and Transcriptome |